Israel-based Kamada has received the US patent for Transferrin, a highly purified human protein which functions as an iron carrier.
Subscribe to our email newsletter
Kamada’s Transferrin has potential for utilization in the pharmaceutical industry as a targeting molecule for highly metabolizing cells with high iron requirement (cancerous or infected) cells. Kamada, which has been producing and marketing industrial quantities of high purity human Transferrin (Tf) for tissue culture use, is planning to develop a pharmaceutical product given its proprietary know-how and expertise.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.